Sichuan Kelun Pharmaceutical Co Ltd
Company Profile
Business description
Sichuan Kelun Pharmaceutical Co Ltd is a China-based pharmaceutical company focused on the manufacturing of infusion products, antibiotics, and various medical devices. The company operates its businesses through three segments. The Twinings segment focuses on producing pharmaceutical intermediates. The Botai segment is dedicated to the research, development, manufacturing, and commercialization of medicines. The Other Business segment covers activities such as the development and production of large-volume injections, along with the research, manufacturing, and sales of additional pharmaceutical products and related businesses.
Contact
No. 36, Baihua West Road
Qingyang District
Chengdu610071
CHNT: +86 2882860516
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - General
Fiscal Year End
31 December 2026
Employees
20,127
Stocks News & Analysis
stocks
Chart of the Week: CGT reform strengthens the case for dividend investing
stocks
Finding ASX opportunities in lofty market conditions
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,167.30 | 18.20 | -0.20% |
| CAC 40 | 8,408.27 | 50.51 | -0.60% |
| DAX 40 | 25,460.48 | 3.53 | -0.01% |
| Dow JONES (US) | 51,594.14 | 1,153.18 | -2.19% |
| FTSE 100 | 10,908.41 | 37.39 | 0.34% |
| HKSE | 25,747.63 | 60.29 | -0.23% |
| NASDAQ | 24,442.94 | 433.97 | -1.74% |
| Nikkei 225 | 62,674.49 | 1,240.30 | 2.02% |
| NZX 50 Index | 13,778.98 | 197.69 | -1.41% |
| S&P 500 | 7,316.15 | 112.63 | -1.52% |
| S&P/ASX 200 | 9,007.90 | 16.90 | -0.19% |
| SSE Composite Index | 3,831.92 | 3.45 | 0.09% |